Business
Bayer CEO Rules Out Breakup, Says Spinoffs Would Be a Distraction
Bayer’s BAYN 2.01%increase; up pointing triangle Chief Executive Bill Anderson ruled out a breakup of the group’s operations for now, saying the company still has work to do before it can consider options.
The German conglomerate is focused on containing litigation uncertainty, reducing debt and internal bureaucracy, strengthening the drug pipeline of its pharma business, and improving the profitability of its agriculture unit. Anderson said Bayer wouldn’t allow discussions on potential sales or spinoffs of its divisions to become a distraction.
Copyright ©2026 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
You must be logged in to post a comment Login